These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 10378956)

  • 1. Pharmacological treatment of anxiety in the medically ill patient.
    Rubey RN; Lydiard RB
    Semin Clin Neuropsychiatry; 1999 Apr; 4(2):133-47. PubMed ID: 10378956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychopharmacologic treatment of anxiety in the medically ill elderly patient: special considerations.
    Stoudemire A; Moran MG
    J Clin Psychiatry; 1993 May; 54 Suppl():27-33; discussion 34-6. PubMed ID: 8099576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combined treatment approach to anxiety in the medically ill.
    Wise MG; Griffies WS
    J Clin Psychiatry; 1995; 56 Suppl 2():14-9. PubMed ID: 7844102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and psychopharmacology of anxiety in medical patients.
    Stoudemire A
    J Clin Psychiatry; 1996; 57 Suppl 7():64-72; 73-5. PubMed ID: 8690699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic considerations and treatment approaches to underlying anxiety in the medically ill.
    Wise MG; Rieck SO
    J Clin Psychiatry; 1993 May; 54 Suppl():22-6; discussion 34-6. PubMed ID: 8099575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of anxiety and depression in transplant patients: pharmacokinetic considerations.
    Crone CC; Gabriel GM
    Clin Pharmacokinet; 2004; 43(6):361-94. PubMed ID: 15086275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiety and mood disorders in medically ill patients.
    Wise MG; Taylor SE
    J Clin Psychiatry; 1990 Jan; 51 Suppl():27-32. PubMed ID: 2404001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anxiety in the medically ill: nosology and principles of differential diagnosis.
    Skodol AE
    Semin Clin Neuropsychiatry; 1999 Apr; 4(2):64-71. PubMed ID: 10378950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinically relevant drug interactions in anxiety disorders.
    Muscatello MR; Spina E; Bandelow B; Baldwin DS
    Hum Psychopharmacol; 2012 May; 27(3):239-53. PubMed ID: 22311403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology.
    Baldwin DS; Anderson IM; Nutt DJ; Bandelow B; Bond A; Davidson JR; den Boer JA; Fineberg NA; Knapp M; Scott J; Wittchen HU;
    J Psychopharmacol; 2005 Nov; 19(6):567-96. PubMed ID: 16272179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiety in patients with pulmonary disease: comorbidity and treatment.
    Smoller JW; Simon NM; Pollack MH; Kradin R; Stern T
    Semin Clin Neuropsychiatry; 1999 Apr; 4(2):84-97. PubMed ID: 10378952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anxiety; pharmacological bases of treatment].
    de Andrés Rodríguez-Trelles F
    An R Acad Nac Med (Madr); 1981; 98(1):69-116. PubMed ID: 6115590
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of drugs in the treatment of anxiety.
    Vajda FJ; Burrows GD
    Aust Fam Physician; 1983 Oct; 12(10):714-7. PubMed ID: 6141784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
    Lee JH; Dunner DL
    Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug metabolism and drug interaction of anxiolytics].
    Uchimura N; Etou Y
    Ryoikibetsu Shokogun Shirizu; 2003; (38):612-6. PubMed ID: 12877062
    [No Abstract]   [Full Text] [Related]  

  • 16. Recognition and treatment of depression and anxiety in patients with acute myocardial infarction.
    Huffman JC; Smith FA; Blais MA; Beiser ME; Januzzi JL; Fricchione GL
    Am J Cardiol; 2006 Aug; 98(3):319-24. PubMed ID: 16860016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating and treating anxiety disorders in medical settings.
    Ball S; Goddard A; Shekhar A
    J Postgrad Med; 2002; 48(4):317-21. PubMed ID: 12571395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary management of comorbid anxiety and depression in geriatric patients.
    Doraiswamy PM
    J Clin Psychiatry; 2001; 62 Suppl 12():30-5. PubMed ID: 11430616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiety disorders in the 21st century: status, challenges, opportunities, and comorbidity with depression.
    Devane CL; Chiao E; Franklin M; Kruep EJ
    Am J Manag Care; 2005 Oct; 11(12 Suppl):S344-53. PubMed ID: 16236016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and pharmacokinetic aspects of the problem of benzodiazepine derivatives (review of foreign literature)].
    Go'rkov VA; Tarasova TP; Gertsik LG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(5):132-41. PubMed ID: 2571214
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.